Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Kura Oncology (KURA)
NASDAQ:KURA
Kura Oncology (KURA) Stock Price & Analysis
312 Followers
KURA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$10.30 - $19.93
Previous Close$12.03
Volume583.56K
Average Volume (3M)649.50K
Market Cap
$823.32M
Enterprise Value$399.36M
Total Cash (Recent Filing)$437.99M
Total Debt (Recent Filing)$14.02M
Price to Earnings (P/E)-5.9
Beta1.02
Next Earnings
May 09, 2023EPS Estimate
-$0.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.03
Shares Outstanding68,300,000
10 Day Avg. Volume470,947
30 Day Avg. Volume649,504
Standard Deviation0.16
R-Squared0.08
Alpha-0.00015
Financial Highlights & Ratios
Price to Book (P/B)2.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-10.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.96
Forecast
1Y Price Target
$32.44Price Target Upside164.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Kura Oncology News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KURA FAQ
What was Kura Oncology’s price range in the past 12 months?
Kura Oncology lowest stock price was $10.30 and its highest was $19.93 in the past 12 months.
What is Kura Oncology’s market cap?
Currently, no data Available
When is Kura Oncology’s upcoming earnings report date?
Kura Oncology’s upcoming earnings report date is May 09, 2023 which is in 46 days.
How were Kura Oncology’s earnings last quarter?
Kura Oncology released its earnings results on Feb 23, 2023. The company reported -$0.49 earnings per share for the quarter, beating the consensus estimate of -$0.572 by $0.082.
Is Kura Oncology overvalued?
According to Wall Street analysts Kura Oncology’s price is currently Undervalued.
Does Kura Oncology pay dividends?
Kura Oncology does not currently pay dividends.
What is Kura Oncology’s EPS estimate?
Kura Oncology’s EPS estimate is -$0.54.
How many shares outstanding does Kura Oncology have?
Kura Oncology has 68,438,576 shares outstanding.
What happened to Kura Oncology’s price movement after its last earnings report?
Kura Oncology reported an EPS of -$0.49 in its last earnings report, beating expectations of -$0.572. Following the earnings report the stock price went down -2.743%.
Which hedge fund is a major shareholder of Kura Oncology?
Among the largest hedge funds holding Kura Oncology’s share is Deerfield Management Company, LP. It holds Kura Oncology’s shares valued at 30M.
---
Kura Oncology Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$32.44 (164.38% Upside)
$32.44 (164.38% Upside)
Blogger Sentiment
Bullish
KURA Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 103.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $124.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.3%
Last 30 Days ▲ 4.8%
Last 30 Days ▲ 4.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.09%
12-Months-Change
Fundamentals
Return on Equity
-29.31%
Trailing 12-Months
Asset Growth
-14.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Kura Oncology
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.
---
Top 5 ETFs holding KURA
Fidelity Nasdaq Composite Index ETF
$391.53K
Dimensional U.S. Equity ETF
$96.83K
Up to five ETFs with an Outperform Smart Score that hold KURA. The ETFs are listed according to market value of KURA within the ETF
---
Deciphera Pharmaceuticals
―
Biohaven Ltd.
―
Arcutis Biotherapeutics
―
Morphic Holding
―
Lyell Immunopharma
―
---